Administration of D5W and Insulin for Slow Hyperkalemia Correction
For slow correction of hyperkalemia when potassium monitoring is limited for several days, administer insulin at 0.1 unit/kg with 400 mg/kg of glucose (D5W) in a 1:4 ratio, with continuous D5W infusion at maintenance rates to prevent hypoglycemia. 1
Recommended Protocol for Slow Hyperkalemia Correction
Initial Treatment
- Administer regular insulin at 0.1 unit/kg IV with 400 mg/kg of glucose (ratio of 1 unit insulin for every 4g of glucose) 1
- Use D5W as the preferred glucose solution, as it is less irritating to veins than more concentrated solutions 1
- For an average adult, this typically translates to approximately 10 units of regular insulin with 40g of glucose (800mL of D5W) 1
Maintenance Strategy
- Follow initial treatment with continuous D5W infusion at maintenance rate (approximately 100 mL/kg per 24h or 7 mg/kg per min) 1
- This continuous infusion approach provides steady glucose delivery to counteract the prolonged action of insulin 1
- Consider adjusting the rate based on patient's age and weight, as older children and adults may require substantially lower doses 1
Monitoring Requirements
- Check blood glucose 15 minutes after initial treatment and then hourly for at least 4-6 hours 1, 2
- If unable to check glucose frequently, maintain D5W infusion continuously until potassium can be rechecked 1, 3
- Monitor for signs of hypoglycemia (confusion, diaphoresis, tremors) even when laboratory monitoring is limited 1
Special Considerations
Risk Factors for Hypoglycemia
- Patients with renal dysfunction are at higher risk of hypoglycemia due to prolonged insulin action 4
- Patients with low pre-treatment glucose (<110 mg/dL) benefit from higher glucose doses (50g rather than 25g) 5
- Non-diabetic patients may require higher glucose-to-insulin ratios to prevent hypoglycemia 5
Duration of Monitoring
- The effect of insulin on potassium typically lasts 4-6 hours, but hypoglycemic effects may persist longer 4, 2
- When unable to monitor frequently, continuous D5W infusion is essential to prevent delayed hypoglycemia 3
- Consider that hypoglycemic episodes can occur up to 6 hours after insulin administration, particularly in patients with impaired renal function 4
Pitfalls to Avoid
- Avoid rapid administration of concentrated dextrose solutions, which has been associated with cardiac arrest and hyperkalemia 1
- Do not stop glucose administration after initial treatment, as insulin's duration of action typically exceeds that of bolus glucose 2
- Avoid using insulin doses >10 units when monitoring will be limited, as higher doses increase hypoglycemia risk without significantly improving potassium reduction in most cases 6
- Be aware that rebound hyperkalemia can occur days after insulin treatment, especially with large insulin doses 7
This approach balances the need for potassium reduction with the risk of hypoglycemia when monitoring is limited, prioritizing patient safety while still providing effective treatment for hyperkalemia.